Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study

Hetrombopag, a small molecular thrombopoietin-receptor agonist, has shown encouraging efficiency in immunosuppressive therapy refractory or relapsed severe aplastic anaemia. To investigate the response rate of hetrombopag combined with IST as first-line treatment, we designed a prospective pilot stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenrui, Zhao, Xin, Liu, Xu, Xiong, Youzhen, Fan, Huihui, Zhang, Li, Li, Jianping, Ye, Lei, Zhou, Kang, Li, Yuan, Yang, Yang, Peng, Guangxin, Jing, Liping, Zhang, Fengkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890734/
https://www.ncbi.nlm.nih.gov/pubmed/36726169
http://dx.doi.org/10.1186/s40164-023-00377-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890734/
https://www.ncbi.nlm.nih.gov/pubmed/36726169
http://dx.doi.org/10.1186/s40164-023-00377-3

Ejemplares similares